De-Wei Lai | Microbiology | Best Scholar Award

Posted on by Shen Awards

Prof. Dr. De-Wei Lai | Microbiology | Best Scholar Award

Associate Researcher at Taichung Veterans General Hospital, Taiwan

Dr. De-Wei Lai is an accomplished Associate Researcher at the Department of Medical Research, Taichung Veterans General Hospital, Taiwan. With a strong foundation in applied chemistry and immunology, he has dedicated his career to unraveling the complexities of regulatory T cells in diverse pathological conditions. Dr. Lai’s research spans autoimmunity, regenerative medicine, and the tumor microenvironment, with a focus on innovative immunotherapeutic strategies. His expertise integrates modern molecular techniques with natural extracts and traditional Chinese medicine, aiming to develop novel diagnostic and therapeutic solutions. With over 19 SCI/SCIE-indexed publications, 27 editorial appointments, and 16 awards, Dr. Lai has established himself as a leading voice in immunological research. His work, characterized by precision and translational potential, continues to shape the future of immunotherapy.

Professional Profile

Education

Dr. De-Wei Lai completed his undergraduate studies in Applied Chemistry at National Pingtung University, where he developed a deep interest in cellular metabolism and biochemical signaling pathways. He later pursued a Ph.D. in Immunology, focusing on the molecular mechanisms underlying diabetic retinopathy, which culminated in a groundbreaking publication in Circulation Research. His academic journey is marked by excellence in understanding complex immunological pathways and leveraging this knowledge for practical medical applications.

Professional Experience

Dr. Lai began his research career in 2019 at Chang Bing Show Chwan Memorial Hospital, where he studied the isolation, cultivation, and functional analysis of regulatory T cells (Tregs). His work laid the foundation for significant advancements in immunotherapy. In 2024, he joined Taichung Veterans General Hospital, where he expanded his focus to include molecular mechanisms of Tregs in autoimmune diseases, regenerative medicine, and tumor microenvironments. Throughout his career, Dr. Lai has consistently contributed to high-impact research, addressing critical gaps in clinical immunology and advancing innovative therapeutic strategies.

Research Interests

Dr. Lai’s research interests lie at the intersection of immunotherapy, molecular biology, and regenerative medicine. His laboratory explores the molecular mechanisms of regulatory T cells in autoimmune diseases, age-related degenerative conditions, and cancer. Recently, Dr. Lai has extended his work to study the potential of natural extracts, traditional Chinese medicine, and metal-organic nanoparticles as modulators of the immune system. By integrating experimental models with clinical big data, his research aims to develop novel diagnostic tools and immunotherapeutic strategies that address pressing medical challenges.

Research Skills

Dr. Lai possesses a robust skill set in immunological research and molecular biology. His expertise includes regulatory T cell isolation and expansion, animal model development for autoimmune diseases, and the study of tumor microenvironments. He is proficient in advanced techniques such as flow cytometry, immunohistochemistry, and molecular signaling analysis. His interdisciplinary approach also incorporates the evaluation of natural compounds and nanoparticles for therapeutic applications. With strong analytical skills and an eye for innovation, Dr. Lai excels in bridging basic research with translational medicine.

Awards and Honors

Dr. Lai’s contributions to immunological research have been widely recognized. He has received 16 awards and recognitions, highlighting his impact in both academic and clinical settings. These honors reflect his groundbreaking discoveries in T cell biology, innovative therapeutic approaches, and commitment to advancing immunotherapy. His editorial appointments in 27 journals and conferences further underscore his standing in the scientific community as a trusted authority in immunological research. Dr. Lai’s dedication to addressing clinical challenges continues to earn him accolades and inspire future research efforts.

Conclusion

Dr. De-Wei Lai is an excellent candidate for the Best Scholar Award due to his exceptional research achievements, dedication to addressing clinical challenges, and innovative approach to immunotherapy. While he excels in academic publication and editorial roles, areas like project leadership, patents, and international collaborations offer room for growth. Overall, his contributions to immunology and translational medicine make him a strong contender for this recognition.

Publications Top Notes

  • Melatonin set out to ER stress signaling thwarts epithelial mesenchymal transition and peritoneal dissemination via calpain‐mediated C/EBP β and NF κ B cleavage
    • Authors: SM Wu, WY Lin, CC Shen, HC Pan, W Keh‐Bin, YC Chen, YJ Jan, DW Lai, …
    • Journal: Journal of Pineal Research, 60 (2), 142-154
    • Year: 2016
    • Citations: 98
  • Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress, and inhibiting epithelial-to-mesenchymal transition
    • Authors: SH Liu, WJ Lee, DW Lai, SM Wu, CY Liu, HR Tien, CS Chiu, YC Peng, …
    • Journal: Molecular Oncology, 9 (4), 834-849
    • Year: 2015
    • Citations: 64
  • Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model
    • Authors: HC Pan, DW Lai, KH Lan, CC Shen, SM Wu, CS Chiu, KB Wang, …
    • Journal: Carcinogenesis, 34 (11), 2568-2579
    • Year: 2013
    • Citations: 45
  • Aryl hydrocarbon receptor deficiency attenuates oxidative stress-related mesangial cell activation and macrophage infiltration and extracellular matrix accumulation in diabetic nephropathy
    • Authors: WJ Lee, SH Liu, CK Chiang, SY Lin, KW Liang, CH Chen, HR Tien, …
    • Journal: Antioxidants & Redox Signaling, 24 (4), 217-231
    • Year: 2016
    • Citations: 44
  • The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination
    • Authors: DW Lai, SH Liu, AI Karlsson, WJ Lee, KB Wang, YC Chen, CC Shen, …
    • Journal: Oncotarget, 5 (17), 7788
    • Year: 2014
    • Citations: 43
  • Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways
    • Authors: CS Chiu, CH Tsai, MS Hsieh, SC Tsai, YJ Jan, WY Lin, DW Lai, SM Wu, …
    • Journal: Cancer Letters, 442, 113-125
    • Year: 2019
    • Citations: 42
  • TPL2 (therapeutic targeting tumor progression locus-2)/ATF4 (activating transcription factor-4)/SDF1α (chemokine stromal cell-derived factor-α) axis suppresses diabetic retinopathy
    • Authors: DW Lai, KH Lin, WHH Sheu, MR Lee, CY Chen, WJ Lee, YW Hung, …
    • Journal: Circulation Research, 121 (6), e37-e52
    • Year: 2017
    • Citations: 37
  • Attenuation of in vitro and in vivo melanin synthesis using a Chinese herbal medicine through the inhibition of tyrosinase activity
    • Authors: SC Liu, ML Sheu, YC Tsai, YC Lin, CW Chang, DW Lai
    • Journal: Phytomedicine, 95, 153876
    • Year: 2022
    • Citations: 22
  • Melatonin protects retinal integrity through mediated immune homeostasis in the sodium iodate-induced mouse model of age-related macular degeneration
    • Authors: LC Ku, ML Sheu, HH Cheng, CY Lee, YC Tsai, CY Tsai, KH Lin, LC Lai, …
    • Journal: Biomedicine & Pharmacotherapy, 161, 114476
    • Year: 2023
    • Citations: 10
  • AHR/TET2/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression
    • Authors: HH Cheng, L Hung‐Ke, ML Sheu, CY Lee, YC Tsai, DW Lai
    • Journal: Immunology, 168 (4), 654-670
    • Year: 2023
    • Citations: 8

 

Hilal Ünsal | Immunology and Microbiology | Best Researcher Award

Posted on by Shen Awards

Dr. Hilal Ünsal | Immunology and Microbiology | Best Researcher Award

Hacettepe University Faculty of Medicine, Department of Pediatric Immunology and Allergy at Hacettepe University Faculty of Medicine, Turkey

Dr. Hilal Ünsal is a distinguished pediatric allergist and clinical immunologist specializing in the diagnosis and management of allergies and immunodeficiencies in children. With extensive training and clinical experience, Dr. Ünsal has become a prominent figure in the field of pediatric allergy, contributing significantly to both clinical practice and research. Currently pursuing advanced studies in Pediatric Allergy and Clinical Immunology at Hacettepe University, she combines her clinical expertise with a strong research background, particularly in primary immunodeficiencies, food allergies, and asthma. Her work has been published in several reputable journals, and she is an active participant in international conferences, reflecting her commitment to advancing medical knowledge and improving patient outcomes.

Professional Profile

Education

Dr. Ünsal earned her Medical Degree from Gazi University, Faculty of Medicine in 2012, where she graduated as an honor student. She then pursued a residency in pediatrics at Health Sciences University Dr. Sami Ulus Maternity, Child Health and Diseases Training and Research Hospital, completing her training in 2018. Currently, she is completing a Clinical Fellowship in Pediatric Allergy and Clinical Immunology at Hacettepe University, a program that is enhancing her expertise in the immunologic aspects of pediatric diseases. Dr. Ünsal’s academic path reflects her dedication to continuous learning and professional growth in the medical field.

Professional Experience

Dr. Ünsal’s professional journey has been centered on pediatric allergy and immunology. After completing her medical education and residency, she further honed her skills in pediatric immunology during her fellowship at Hacettepe University, one of Turkey’s leading medical institutions. Over the years, Dr. Ünsal has actively contributed to the diagnosis and management of pediatric allergies, asthma, and immunodeficiencies, working in various clinical settings. Her experience spans the diagnosis of IgE-mediated food allergies, asthma exacerbations, and immunodeficiencies, as well as advanced research in these areas. She has gained a reputation for her meticulous approach to clinical research and patient care.

Research Interests

Dr. Ünsal’s research focuses on the intricate relationships between primary immunodeficiencies, genetics, and pediatric allergies. Her specific interests include food allergies, drug allergies, allergic rhinitis, and asthma, with a strong emphasis on understanding the genetic and immunological factors contributing to these conditions in children. She is particularly dedicated to identifying novel allergens and improving diagnostic methods for food allergies, as well as exploring the role of oxidative stress in asthma. Through her research, Dr. Ünsal aims to improve the quality of life for children suffering from these conditions by enhancing early diagnosis, treatment strategies, and prevention methods.

Research Skills

Dr. Ünsal has developed robust research skills, particularly in the areas of biostatistics, immunological testing, and clinical research methodologies. She is proficient in using SPSS for data analysis, enabling her to conduct rigorous statistical evaluations of her research data. Her research skills are further enhanced by her involvement in multiple projects on food allergies, asthma, and immunodeficiencies. Dr. Ünsal’s expertise in interpreting complex immunological data, along with her ability to work with diverse patient populations, has allowed her to contribute to significant studies in her field. Her active participation in both clinical and experimental research ensures that her work remains at the forefront of pediatric allergy and immunology.

Awards and Honors

Dr. Ünsal’s academic and research excellence has been recognized by her peers and academic institutions. As an honor student at Gazi University, she demonstrated early promise in her medical career. Her ongoing contributions to the field of pediatric allergy and immunology have earned her opportunities to present at numerous prestigious conferences, including the European Academy of Allergy and Clinical Immunology (EAACI) Congress and the World Allergy Congress. Additionally, her research has been published in well-regarded journals such as Pediatric Allergy and Immunology and Turkish Journal of Medical Sciences, which highlights her commitment to advancing knowledge in her field.

Conclusion

Dr. Hilal Ünsal is highly deserving of the Best Researcher Award based on her extensive body of work, leadership in research, and active participation in international conferences. Her expertise in pediatric immunology and allergy is well-documented, and her ongoing research in immunodeficiencies and food allergies is crucial for advancing clinical practice in these areas. While further strengthening her clinical impact and broadening her research funding could enhance her profile, her current contributions to the field place her as a prominent figure in her discipline. Dr. Ünsal is well-positioned for continued excellence in research, making her an excellent candidate for this prestigious award

Publication Top Notes

  1. Title: The treatment journey of children with moderate to severe atopic dermatitis in Türkiye: unmet needs
    • Authors: İlgün Gürel, D., Ünsal, H., Soyak Aytekin, E., Ersoy Evans, S., Şekerel, B.E.
    • Year: 2024
  2. Title: A large single-center cohort of bare lymphocyte syndrome: Immunological and genetic features in Turkey
    • Authors: Ünsal, H., Caka, C., Bildik, H.N., Tezcan, İ., Çağdaş, D.
    • Year: 2024
    • Citations: 2
  3. Title: Cupressus arizonica: an emerging aeroallergen for East Mediterranean children
    • Authors: Ünsal, H., Şahiner, Ü.M., Soyer, Ö., Şekerel, B.E.
    • Year: 2023
  4. Title: Phenotypes of persistent hen’s egg allergy in children and adolescents
    • Authors: Ünsal, H., Dal, S.T., Akarsu, A., Soyer, Ö., Şekerel, B.E.
    • Year: 2023
    • Citations: 2
  5. Title: Obesity is a risk factor for decrease in lung function after COVID-19 infection in children with asthma
    • Authors: Soyak Aytekin, E., Sahiner, U.M., Tuten Dal, S., Sekerel, B.E., Soyer, O.
    • Year: 2022
    • Citations: 9
  6. Title: IgE mediated legume allergy in east Mediterranean children: A reflection of multiple food allergies
    • Authors: Soyak Aytekin, E., Unsal, H., Sahiner, U.M., Soyer, O., Sekerel, B.E.
    • Year: 2022
    • Citations: 4
  7. Title: Comparison of miRNA expression in patients with seasonal and perennial allergic rhinitis and non-atopic asthma
    • Authors: Tunçer, F., Şahiner, Ü.M., Ocak, M., Şekerel, B.E., Birben, E.
    • Year: 2022
    • Citations: 4
  8. Title: Clinical Validation of the Spirohome Clinic Ultrasonic Spirometer in Child and Adolescent Patients
    • Authors: Sekerel, B.E., Unsal, H., Sahiner, U.M., Karakaya, G., Kalyoncu, A.F.
    • Year: 2022
    • Citations: 5
  9. Title: Food allergy management has been negatively impacted during the COVID-19 pandemic
    • Authors: Soyak Aytekin, E., Tüten Dal, S., Ünsal, H., Soyer, Ö., Şekerel, B.E.
    • Year: 2021
    • Citations: 2
  10. Title: Allergic reactions against COVID-19 vaccines
    • Authors: Ünsal, H., Şekerel, B.E., Şahiner, Ü.M.
    • Year: 2021
    • Citations: 4

 

Han Young Chung | Pathogenic Microbiology | Best Researcher Award

Posted on by Shen Awards

Prof. Han Young Chung | Pathogenic Microbiology | Best Researcher Award

Associate Professor at Chungnam National University/College of Pharmacy, South Korea

Dr. Han Young Chung is an accomplished Assistant Professor at the College of Pharmacy, Chungnam National University, South Korea. With a Ph.D. in Molecular Microbiology and Toxicology from Seoul National University, Dr. Chung has an extensive background in gastroenterology research, having completed post-doctoral fellowships at The University of Michigan and Seoul National University. He has received multiple honors, including the Best Presentation Award from the Korean Society for Microbiology and Biotechnology and several prestigious scholarships. Dr. Chung has successfully secured research funding, notably leading a Creative Challenge Project funded by the National Research Foundation of Korea. His prolific publication record includes numerous articles in high-impact journals, focusing on food safety and pathogenic microorganisms. He has also presented his research internationally, contributing to advancements in understanding microbial interactions and pathogenesis. Dr. Chung’s dedication to research and teaching makes him a strong candidate for the Best Researcher Award.

Profile

Education

Dr. Han Young Chung has an impressive educational background that underpins his expertise in the field of molecular microbiology and toxicology. He completed his Bachelor’s degree in Biotechnology and Bioinformatics, graduating cum laude from Korea University in 2013, where he achieved an overall GPA of 4.4/4.5. Following this, he pursued his Ph.D. at Seoul National University, where he specialized in Molecular Microbiology and Toxicology. Dr. Chung excelled in his studies, earning a remarkable overall GPA of 4.11/4.3 while completing 60 credits from September 2013 to August 2020. After obtaining his doctorate, he enhanced his research experience as a Post-Doctoral Fellow at the University of Michigan Medical School from September 2022 to February 2024 and previously at the Center for Food and Bioconvergence at Seoul National University. His educational journey reflects a strong foundation in scientific research and dedication to advancing knowledge in his field.

Professional Experience

Dr. Han Young Chung is currently serving as an Assistant Professor at the College of Pharmacy, Chungnam National University in South Korea since March 2024. Prior to this role, he was a Post-Doctoral Fellow in the Division of Gastroenterology at the University of Michigan Medical School from September 2022 to February 2024. Dr. Chung also held the position of Research Assistant Professor at the Center for Food and Bioconvergence, Seoul National University (SNU), from June 2021 to August 2022, after completing another Post-Doctoral Fellowship at SNU from September 2020 to May 2021. His academic journey began with a Ph.D. in Molecular Microbiology and Toxicology from SNU (2013-2020) and a Bachelor’s degree in Biotechnology and Bioinformatics from Korea University (2009-2013). Throughout his career, Dr. Chung has contributed significantly to the fields of microbiology and toxicology, demonstrating a strong commitment to research and education.

Research Interest

Dr. Han Young Chung’s research interests lie at the intersection of molecular microbiology and toxicology, with a strong focus on food safety and pathogen virulence. His work explores the interactions between foodborne pathogens, such as Vibrio vulnificus and Staphylococcus aureus, and their impact on human health, particularly in relation to thrombosis and other adverse health outcomes. Dr. Chung employs advanced genomic and transcriptomic analyses to investigate the pathogenic mechanisms of these microbes, aiming to uncover insights that could enhance food safety measures. Additionally, he is interested in the role of nanomaterials, such as nanoplastics, in promoting coagulation and thrombus formation, which can have significant implications for public health. His interdisciplinary approach combines microbiology, toxicology, and bioinformatics, positioning him as a leader in research that addresses pressing issues in food safety and microbial pathogenesis.

Research Skills

Dr. Han Young Chung possesses a diverse and robust skill set in research, primarily focusing on molecular microbiology and toxicology. His expertise includes advanced techniques in genome and transcriptome analysis, enabling him to investigate the genetic makeup and pathogenicity of various microorganisms, particularly food-borne pathogens. He has significant experience in experimental design, data analysis, and interpretation, which he has demonstrated through numerous high-impact publications in reputable SCI journals. Dr. Chung is proficient in conducting in vitro and in vivo studies, utilizing cutting-edge methodologies such as nanotechnology and high-throughput sequencing. His ability to collaborate effectively with interdisciplinary teams has led to successful projects, including significant grants and innovative research initiatives. Furthermore, Dr. Chung’s strong presentation skills have enabled him to share his findings at international conferences, enhancing the visibility of his research and contributing to the global scientific community. Overall, his comprehensive research skills make him a valuable asset in the field.

Award and Recognition

Dr. Han Young Chung is a distinguished researcher currently serving as an Assistant Professor at the College of Pharmacy, Chungnam National University, South Korea. He holds a Ph.D. in Molecular Microbiology and Toxicology from Seoul National University and has completed post-doctoral fellowships at The University of Michigan Medical School and Seoul National University. Dr. Chung has received several honors, including the Best Presentation Award from the Korean Society for Microbiology and Biotechnology and the Best Performance Award during his undergraduate research program at Hanyang University. His research, which focuses on the pathogenesis of foodborne pathogens, has led to significant publications in high-impact journals, including Nature Communications and Particulate Science and Technology. Dr. Chung’s work has been supported by grants such as the National Research Foundation of Korea, underscoring his contribution to advancing scientific knowledge in his field. His innovative research and dedication make him a strong candidate for the Best Researcher Award.

Conclusion

Dr. Han Young Chung exemplifies the qualities of a leading researcher through his robust academic background, significant research contributions, and recognition in his field. His expertise in molecular microbiology and toxicology addresses critical issues in food safety and public health, making him a deserving candidate for the Best Researcher Award. By focusing on broader collaboration, mentorship, and public engagement, he can further enhance his impact in the scientific community and beyond. Recognizing his achievements with this award will not only honor his contributions but also inspire future researchers in the field.

Publication Top Notes
  • Loss of integrity: impairment of the blood-brain barrier in heavy metal-associated ischemic stroke
    • Authors: JH Kim, HM Byun, EC Chung, HY Chung, ON Bae
    • Year: 2013
    • Journal: Toxicological Research
    • Volume/Issue/Page: 29, 157-164
  • Analysis of microbiota on abalone (Haliotis discus hannai) in South Korea for improved product management
    • Authors: MJ Lee, JJ Lee, HY Chung, SH Choi, BS Kim
    • Year: 2016
    • Journal: International Journal of Food Microbiology
    • Volume/Issue/Page: 234, 45-52
  • Molecular interaction between methicillin-resistant Staphylococcus aureus (MRSA) and chicken breast reveals enhancement of pathogenesis and toxicity for food-borne outbreak
    • Authors: HY Chung, YT Kim, JG Kwon, HH Im, D Ko, JH Lee, SH Choi
    • Year: 2021
    • Journal: Food Microbiology
    • Volume/Issue/Page: 93, 103602
  • Rapid, simultaneous and nanomolar determination of pyroglutamic acid and cis-/trans-urocanic acid in human stratum corneum by hydrophilic interaction liquid chromatography …
    • Authors: KM Joo, JY Han, ED Son, GW Nam, HY Chung, HJ Jeong, JC Cho, …
    • Year: 2012
    • Journal: Journal of Chromatography B
    • Volume/Issue/Page: 897, 55-63
  • Amine-modified nanoplastics promote the procoagulant activation of isolated human red blood cells and thrombus formation in rats
    • Authors: EH Kim, S Choi, D Kim, HJ Park, Y Bian, SH Choi, HY Chung, ON Bae
    • Year: 2022
    • Journal: Particle and Fibre Toxicology
    • Volume/Issue/Page: 19(1), 60
  • Titanium dioxide nanoparticles enhance thrombosis through triggering the phosphatidylserine exposure and procoagulant activation of red blood cells
    • Authors: Y Bian, HY Chung, ON Bae, KM Lim, JH Chung, J Pi
    • Year: 2021
    • Journal: Particle and Fibre Toxicology
    • Volume/Issue/Page: 18, 1-12
  • Inhibitory effects of black soybean on platelet activation mediated through its active component of adenosine
    • Authors: K Kim, KM Lim, HJ Shin, DB Seo, JY Noh, S Kang, HY Chung, S Shin, …
    • Year: 2013
    • Journal: Thrombosis Research
    • Volume/Issue/Page: 131(3), 254-261
  • Complete genome sequence of Vibrio vulnificus FORC_017 isolated from a patient with a hemorrhagic rash after consuming raw dotted gizzard shad
    • Authors: HY Chung, YT Kim, S Kim, EJ Na, HJ Ku, KH Lee, ST Heo, S Ryu, H Kim, …
    • Year: 2016
    • Journal: Gut Pathogens
    • Volume/Issue/Page: 8, 1-6
  • Complete genome of Vibrio parahaemolyticus FORC014 isolated from the toothfish
    • Authors: S Ahn, HY Chung, S Lim, K Kim, S Kim, EJ Na, K Caetano-Anolles, …
    • Year: 2016
    • Journal: Gut Pathogens
    • Volume/Issue/Page: 8, 1-6
  • Comparative genomic analysis reveals genetic features related to the virulence of Bacillus cereus FORC_013
    • Authors: HJ Koo, S Ahn, HY Chung, S Kim, K Kim, S Ryu, JH Lee, SH Choi, H Kim
    • Year: 2017
    • Journal: Gut Pathogens
    • Volume/Issue/Page: 9, 1-8

 

 

Muthuselvam Durai | Biological Sciences | Best Researcher Award

Posted on by Shen Awards

Dr. Muthuselvam Durai | Biological Sciences | Best Researcher Award

Assistant Professor, Bishop Heber College (Autonomous) Tiruchirappalli, India.

Muthuselvam D. is an accomplished academic and researcher with a Ph.D. in Botany and over seven years of certified research experience. Currently serving as an Assistant Professor in the Department of Botany at Bishop Heber College, he has made significant contributions to the study of plant-based cosmoceuticals and their effects on skin health. His research focuses on evaluating the safety and efficacy of herbal cosmetics, addressing concerns about phytophototoxicity. Muthuselvam has also completed a funded project on mushroom cultivation, promoting entrepreneurship among students. His academic excellence is reflected in numerous accolades, including the Junior Young Scientist Award and the prestigious Jawaharlal Nehru Memorial Fund Scholarship. In addition to his research, he is a recognized Ph.D. advisor and mentor, guiding students in advanced botanical studies. With a keen interest in advancing sustainable plant-based solutions, Muthuselvam continues to make impactful contributions to the field of botany.

Profile:

Education

Dr. Muthuselvam D. has a robust academic background in the field of Botany, beginning with his Bachelor of Science degree from Bishop Heber College, Trichy, where he graduated in 2002. He pursued a Master of Science in Botany at Jamal Mohamed College, Trichy, completing it in 2004 with a solid foundation in plant biology. In 2005, Dr. Muthuselvam earned an M.Phil. in Botany from St. Joseph’s College, Trichy, graduating with distinction (81.2%). His M.Phil. research focused on antimicrobial screening and phytochemical analysis, adding to his expertise in plant-based studies. Dr. Muthuselvam went on to obtain his Ph.D. from St. John’s College, Agra, under Dr. B.R. Ambedkar University. His doctoral thesis, highly commended by the university, explored the evaluation of plant-based cosmeceuticals with special reference to phytophototoxicity, contributing valuable insights into the safety of herbal cosmetic formulations. This academic journey laid the foundation for his extensive research and teaching career.

Professional Experience

Muthuselvam D. has extensive experience in academia and research, currently serving as an Assistant Professor in the Department of Botany at Bishop Heber College, Trichy, since June 2013. His academic career is complemented by earlier roles, including his position as a Project Associate at the Indian Institute of Technology (IIT) Madras, where he worked from December 2011 to June 2013 on chemical engineering projects. Prior to that, he gained experience as a Geochemist Assistant in the Public Works Department, Taramani, from 2010 to November 2011. His academic journey includes seven years of certified research experience during his M.Sc., M.Phil., and Ph.D. programs. Muthuselvam has also contributed to education by teaching M.Sc. and B.Sc. students as a Research Scholar at St. John’s College, Agra. His expertise in botany, project management, and mentorship has earned him recognition in both academic and research circles.

Research Interests

Muthuselvam D.’s research interests primarily focus on plant-based cosmoceuticals, with a special emphasis on evaluating their safety and efficacy in skincare applications. His Ph.D. research centered around the phytophototoxic effects of plant-derived cosmetic formulations, aiming to identify and mitigate potential adverse reactions in products like moisturizers, sunscreens, and cleansers. In addition to cosmoceuticals, Muthuselvam has explored antimicrobial screening and phytochemical analysis of medicinal plants, such as Sphaeranthus indicus, highlighting his interest in the therapeutic properties of botanicals. His work also includes studies on the effects of gamma irradiation on crop varieties, investigating genetic, morphological, and biochemical changes. Through his diverse research endeavors, Muthuselvam seeks to bridge the gap between traditional plant-based knowledge and modern scientific applications, with a long-term goal of contributing to safer and more effective uses of botanicals in healthcare and cosmetics. His interdisciplinary approach integrates botany, biotechnology, and plant biology.

Award and Recognition

Muthuselvam D. has received several awards and recognitions that highlight his academic and research excellence. He was honored with the Junior Young Scientist Award for his outstanding oral presentation at the National Seminar on Medicinal Plants in 2007, organized by the Department of Zoology and Environment Science at Gurukul Kangri Vishwavidyalaya, Haridwar. Additionally, he was awarded the Dr. V.K. George Endowment Cash Award and the College Management Medal from St. Joseph’s College, Tiruchirappalli, for his academic achievements. Muthuselvam also received the prestigious Jawaharlal Nehru Memorial Fund Scholarship from January 2008 to June 2009, further recognizing his potential and contributions in the field of botany. As a research scholar, he served as the Botanical Society Research Scholar Representative at St. John’s College, Agra. These accolades reflect Muthuselvam’s commitment to research, academic leadership, and his significant contributions to botanical science.

Conclusion

Muthuselvam D. has a strong academic and research background, marked by multiple achievements and awards. His experience in both research and teaching positions, along with a completed funded project, make him a strong candidate for the Research for Best Scholar Award. However, bolstering his profile with more recent publications and international collaborations could further enhance his competitiveness for the award.

 

 

Elena Prokopyeva | Immunology and Microbiology | Life Sciences Innovation Award

Posted on by Shen Awards

Dr. Elena Prokopyeva | Immunology and Microbiology | Life Sciences Innovation Award

Senior Researcher of Novosibirsk state university, Russia.

Elena Prokopyeva is a distinguished researcher and educator based at the Federal Research Center of Fundamental and Translational Medicine in Novosibirsk, Russia. Her academic journey began at Novosibirsk State University and progressed through advanced research positions at institutions like the FBRI State Research Center of Virology and Biotechnology ‘Vector’. Dr. Prokopyeva holds a PhD focused on the phenotypic and genotypic properties of influenza viruses and has made significant contributions to virology, studying various viruses including influenza, coronaviruses, and adenoviruses. Her expertise extends to virological methods, immunohistochemistry, and serological diagnostics. Dr. Prokopyeva has authored numerous high-impact publications, reflecting her extensive research in infectious diseases and cell biology. She is also a reviewer for MDPI and an expert for the Russian Science Foundation. Her achievements, coupled with her teaching roles in embryology and histology, underscore her valuable contributions to the scientific community.

Profile
Education

Elena Prokopyeva completed her undergraduate studies at Novosibirsk State University (NSU) from 2003 to 2009, where she specialized in Natural Science with a focus on Physiology. She pursued her graduate studies at the Institute of Molecular Biology and Biophysics, Siberian Branch of the Russian Academy of Medical Sciences, from 2009 to 2010, earning expertise in Biochemistry. Her research career began in earnest at the FBRI State Research Center of Virology and Biotechnology ‘Vector’, where she was a Researcher Graduate student from 2010 to 2013, focusing on Virology and Cell Biology. Prokopyeva earned her PhD in December 2015 from the same center, with a thesis on the phenotypic and genotypic properties of pandemic influenza A(H1N1)pdm09 virus. She has continued her academic and research activities at the Federal Research Center of Fundamental and Translational Medicine since 2013.

Professional Experience

Elena Prokopyeva has a distinguished career in virology and molecular biology, marked by extensive research and teaching roles. She began her academic journey at Novosibirsk State University, where she pursued undergraduate studies in natural science and later advanced her education with a PhD at the State Research Center of Virology and Biotechnology ‘Vector’. Her professional experience includes significant roles as a researcher at the Federal Research Center of Fundamental and Translational Medicine (FRC FTM) and as a lecturer in “Embryology,” “General Histology,” and “Special Histology” at Novosibirsk State University. Prokopyeva’s expertise spans virological methods, immunofluorescence, and serological diagnostics, with a focus on infectious diseases and cell biology. She has also contributed as a reviewer for MDPI and an expert for the Russian Science Foundation, reflecting her influence in the scientific community.

Research Interest

Elena Prokopyeva’s research primarily focuses on virology, particularly the study of influenza and other respiratory viruses. Her work explores the phenotypic and genotypic properties of pandemic influenza strains and their adaptation in various animal models. Prokopyeva has conducted significant research on the genetic diversity of adenoviruses and the impact of SARS-CoV-2 on respiratory infections in children. Her expertise extends to the characterization of avian and human respiratory viruses, including their interaction with host cells and susceptibility to antiviral treatments. Additionally, Prokopyeva investigates the molecular mechanisms underlying viral pathogenesis and employs advanced techniques such as immunofluorescence, real-time PCR, and electron microscopy to enhance the understanding of infectious diseases. Her contributions aim to improve diagnostic methods and therapeutic strategies for viral infections, reflecting her commitment to advancing the field of virology and infectious disease research.

Research Skills

Elena Prokopyeva possesses a diverse and advanced skill set in research, particularly within virology and infectious diseases. Her expertise includes virological methods such as virus isolation, infection assays, and the determination of virus susceptibility to inhibitors. She is adept in immunofluorescence and immunohistochemistry techniques, essential for studying viral interactions and pathogenesis. Prokopyeva’s proficiency extends to serological diagnostics using hemagglutination and microneutralization assays, as well as molecular techniques like RNA/DNA isolation, real-time PCR, and gel electrophoresis. Her experience with light and electron microscopy further enhances her capability to analyze viral structures and disease mechanisms. Prokopyeva’s role as a reviewer and expert for scientific foundations highlights her strong analytical skills and contributions to advancing the field of virology. Her comprehensive research skills, combined with her active participation in professional organizations, underscore her significant impact and ongoing commitment to her field.

Awards and Recognition

Elena Prokopyeva has earned notable recognition for her research in virology and infectious diseases. Her contributions to the field are highlighted by her role as a reviewer for the MDPI and an expert for the Russian Science Foundation, reflecting her expertise and impact on scientific research. Her work has been published in prestigious journals such as Viruses, Biochemistry (Moscow), and the Journal of Infection in Developing Countries, with high citation rates in Web of Science and Scopus. Prokopyeva’s research on influenza viruses and other pathogens has garnered significant attention, underscoring her expertise in studying viral genetic diversity and pathogenic mechanisms. Additionally, her involvement with the Euro-Asian Society for Infectious Diseases marks her as a key figure in advancing knowledge in her field. These accolades affirm her standing as a distinguished researcher and contribute to her recognition for the Best Researcher Award.

Conclusion

Elena Prokopyeva is a strong candidate for the Best Researcher Award due to her extensive research expertise, impressive publication record, and significant contributions to the field of virology. Her work in understanding and combating viral diseases, coupled with her role in educating future scientists, underscores her value as a researcher. Addressing the areas for improvement could further enhance her standing and impact in the scientific community. Overall, Prokopyeva’s achievements and ongoing contributions make her a worthy candidate for the award.

Publications Top Notes

  • “Genetic Diversity of the Human Adenovirus C Isolated from Hospitalized Children in Russia (2019–2022)”
    • Authors: Kurskaya, O.G., Prokopyeva, E.A., Dubovitskiy, N.A., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Viruses
    • Year: 2024
    • Volume: 16(3)
    • Article Number: 386
    • Citations: 1
  • “Constitutive Androstane Receptor Agonist Initiates Metabolic Activity Required for Hepatocyte Proliferation”
    • Authors: Mazin, M.E., Perevalova, A.M., Yarushkin, A.A., Gulyaeva, L.F., Pustylnyak, V.O.
    • Journal: Biochemistry (Moscow)
    • Year: 2023
    • Volume: 88(8)
    • Pages: 1061–1069
  • “Changes in the Etiology of Acute Respiratory Infections among Children in Novosibirsk, Russia, between 2019 and 2022: The Impact of the SARS-CoV-2 Virus”
    • Authors: Kurskaya, O.G., Prokopyeva, E.A., Sobolev, I.A., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Viruses
    • Year: 2023
    • Volume: 15(4)
    • Article Number: 934
    • Citations: 8
  • “Virological and Genetic Characterization of the Unusual Avian Influenza H14Nx Viruses in the Northern Asia”
    • Authors: Dubovitskiy, N., Derko, A., Sobolev, I., Shestopalov, A., Sharshov, K.
    • Journal: Viruses
    • Year: 2023
    • Volume: 15(3)
    • Article Number: 734
    • Citations: 1
  • “Virological and genetic characteristics of human respiratory syncytial viruses isolated in Russia, 2017-2018”
    • Authors: Prokopyeva, E.A., Kurskaya, O.G., Solomatina, M.V., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Journal of Infection in Developing Countries
    • Year: 2023
    • Volume: 17(2)
    • Pages: 251–259
    • Citations: 2
  • “Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation”
    • Authors: Mazin, M.E., Yarushkin, A.A., Pustylnyak, Y.A., Prokopyeva, E.A., Pustylnyak, V.O.
    • Journal: Molecular Biology Reports
    • Year: 2022
    • Volume: 49(5)
    • Pages: 4089–4093
    • Citations: 2
  • “Low incidence of human coronavirus among hospitalized children in Novosibirsk city, Russia during pre-pandemic period (2013–2020)”
    • Authors: Kurskaya, O.G., Prokopyeva, E.A., Anoshina, A.V., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Journal of Microbiology, Immunology and Infection
    • Year: 2022
    • Volume: 55(2)
    • Pages: 336–340
    • Citations: 3
  • “Anti-Influenza Activity of Medicinal Material Extracts from Qinghai–Tibet Plateau”
    • Authors: Kurskaya, O., Prokopyeva, E., Bi, H., Wei, L., Sharshov, K.
    • Journal: Viruses
    • Year: 2022
    • Volume: 14(2)
    • Article Number: 360
    • Citations: 7
  • “Etiology of influenza-like illnesses in the population of Novosibirsk City in the 2018-2019 epidemic season”
    • Authors: Kurskaya, O.G., Anoshina, A.V., Leonova, N.V., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Russian Journal of Infection and Immunity
    • Year: 2021
    • Volume: 11(4)
    • Pages: 723–736
    • Citations: 2
  • “Activation of the Akt pathway by a constitutive androstane receptor agonist results in β-catenin activation”
    • Authors: Yarushkin, A.A., Mazin, M.E., Pustylnyak, Y.A., Prokopyeva, E.A., Pustylnyak, V.O.
    • Journal: European Journal of Pharmacology
    • Year: 2020
    • Volume: 879
    • Article Number: 173135
    • Citations: 6

 

Taher Azimi | Microbioligy | Best Researcher Award

Posted on by Shen Awards

Assist Prof Dr. Taher Azimi | Microbioligy | Best Researcher Award

Faculty member at Shiraz University of Medical Sciences, Iran.

Dr. Taher Azimi is a prominent figure in the field of Environmental Science and Policy, with a diverse background in academia, government, and consultancy. He holds a Bachelor’s degree in Environmental Science and a Master’s degree in Environmental Policy. Dr. Azimi’s professional journey has seen him actively engaged in governmental initiatives, international collaborations, and private sector consulting, all aimed at addressing environmental challenges and promoting sustainable practices. His research interests span various aspects of environmental sustainability, making him a leading authority in shaping policies and practices for a more sustainable future.

Professional Profiles:

Education:

Dr. Taher Azimi completed his Bachelor’s degree in Environmental Science from an esteemed institution, followed by a Master’s degree in Environmental Policy from a renowned university.

Professional Experience

Dr. Taher Azimi began his professional journey by engaging in governmental initiatives aimed at addressing environmental challenges. He played a pivotal role in formulating and implementing policies related to sustainable development, biodiversity conservation, and climate change mitigation. Dr. Azimi’s expertise in environmental law and regulation led to significant contributions in drafting legislation aimed at protecting natural resources and promoting eco-friendly practices in industries. His career trajectory also includes collaborations with international organizations and non-profits dedicated to environmental advocacy. He participated in various projects and campaigns focused on raising awareness about environmental issues and mobilizing action for positive change. Additionally, Dr. Azimi has provided consulting services to private sector entities, offering strategic guidance on adopting environmentally responsible practices and compliance with regulatory standards.

Research Interests

Dr. Taher Azimi’s research interests encompass a wide range of topics within the field of Environmental Science and Policy. Some of his key areas of focus include sustainable development, biodiversity conservation, climate change mitigation and adaptation, environmental law and regulation, and corporate sustainability.

Publications

  1. Prevalence of antibiotic resistance in Escherichia coli strains simultaneously isolated from humans, animals, food, and the environment: a systematic review and …
    • Authors: A Pormohammad, MJ Nasiri, T Azimi
    • Year: 2019
    • Citations: 202
  2. Advanced strategies for combating bacterial biofilms
    • Authors: JY Sharahi, T Azimi, A Shariati, H Safari, MK Tehrani, A Hashemi
    • Year: 2019
    • Citations: 113
  3. Global prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: A systematic review and meta-analysis
    • Authors: A Pormohammad, K Mehdinejadiani, P Gholizadeh, MJ Nasiri, …
    • Year: 2020
    • Citations: 83
  4. Insertional inactivation of oprD in carbapenem-resistant Pseudomonas aeruginosa strains isolated from burn patients in Tehran, Iran
    • Authors: A Shariati, T Azimi, A Ardebili, AS Chirani, A Bahramian, …
    • Year: 2018
    • Citations: 81
  5. Relationship of human herpes virus 6 and multiple sclerosis: a systematic review and meta‐analysis
    • Authors: A Pormohammad, T Azimi, F Falah, E Faghihloo
    • Year: 2018
    • Citations: 76
  6. Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review
    • Authors: T Azimi, M Mosadegh, MJ Nasiri, S Sabour, S Karimaei, A Nasser
    • Year: 2019
    • Citations: 72
  7. The possible role of bacteria, viruses, and parasites in initiation and exacerbation of irritable bowel syndrome
    • Authors: A Shariati, F Fallah, A Pormohammad, A Taghipour, H Safari, AS Chirani, …
    • Year: 2019
    • Citations: 69
  8. Evaluation of Nano-curcumin effects on expression levels of virulence genes and biofilm production of multidrug-resistant Pseudomonas aeruginosa isolated from …
    • Authors: A Shariati, E Asadian, F Fallah, T Azimi, A Hashemi, J Yasbolaghi Sharahi, …
    • Year: 2019
    • Citations: 68
  9. The role of bacteria in the inflammatory bowel disease development: a narrative review
    • Authors: T Azimi, MJ Nasiri, AS Chirani, R Pouriran, H Dabiri
    • Year: 2018
    • Citations: 67
  10. Evaluating the antimicrobial resistance patterns among major bacterial pathogens isolated from clinical specimens taken from patients in Mofid Children’s Hospital, Tehran, Iran …
    • Authors: T Azimi, S Maham, F Fallah, L Azimi, Z Gholinejad
    • Year: 2019
    • Citations: 64